Recap: OrthoPediatrics Q4 Earnings
Portfolio Pulse from Benzinga Insights
OrthoPediatrics (NASDAQ:KIDS) reported Q4 earnings with an EPS of $-0.23, beating estimates by 18.0% and showing a revenue increase of $6.62 million from the previous year. The company has a history of surpassing EPS estimates, which previously led to a 2.0% share price increase.
March 06, 2024 | 9:10 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
OrthoPediatrics reported a positive Q4 earnings surprise with an 18.0% beat on EPS estimates and a significant year-over-year revenue increase.
OrthoPediatrics' positive earnings report, beating EPS estimates by 18.0% and showing a notable revenue increase from the previous year, suggests a potential short-term positive impact on its stock price. Historical data indicates that past earnings beats were followed by share price increases, such as the 2.0% rise after last quarter's earnings beat.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100